U.S. federal cannabis law is at a pivotal moment heading into 2026. In a January 15th webinar, attorneys Jason Adelstone and Vince Sliwoski examined two major federal developments that are poised to reshape the industry: the Executive Order directing the rescheduling of marijuana under the Controlled Substances Act, and new Congressional legislation redefining “hemp,” effective
Harris Sliwoski attorney Jason Adelstone will be participating in CannaGen Sesh 3: Deeply Seeded, a webinar hosted by CannaGen on Thursday, January 22, from 11:00–12:00 PM PST. This session will focus on a significant but underappreciated change in federal hemp law that will materially affect cannabis genetics, seed commerce, and cross-border operations. Under recent amendments
It’s MLK Day once again. I have written an MLK Day post on this blog for nine consecutive years. The theme of all these posts is that cannabis is a civil rights issue, and that Dr. King would have advocated for ending marijuana prohibition based on that fact. Each year, I have demonstrated with facts
Register here Webinar overview This webinar will feature Harris Sliwoski attorneys Jason Adelstone (Denver, CO) and Vince Sliwoski (Portland, OR). Jason and Vince will examine a pair of significant developments for federal cannabis law and policy in 2026. These developments are: 1) last month’s Executive Order from President Trump, to reschedule marijuana from Schedule I
Cannabis law continues to live in constitutional limbo. States like Washington and California have built robust, tightly regulated cannabis markets, while federal law still treats marijuana as contraband. That tension has now collided head‑on with one of the Constitution’s most powerful doctrines: the Dormant Commerce Clause. Just recently, in January 2026, the Ninth Circuit weighed
Register here Webinar overview This webinar will feature Harris Sliwoski attorneys Jason Adelstone (Denver, CO) and Vince Sliwoski (Portland, OR). Jason and Vince will examine a pair of significant developments for federal cannabis law and policy in 2026. These developments are: 1) last month’s Executive Order from President Trump, to reschedule marijuana from Schedule I
What long resembled a Never Ending Story has finally reached a turning point. Today, President Trump signed an Executive Order directing the Attorney General to reschedule marijuana as a Schedule III substance under the Controlled Substances Act (CSA). The signing and remarks can be viewed here. The order includes the following directives (as first reported
On Monday, the U.S. Supreme Court denied certiorari in Canna Provisions, Inc. et al. v. Bondi, a high-profile lawsuit that challenged the constitutionality of the federal prohibition of intrastate (and not interstate) cannabis activity. The denial offered no reasoning; nor was it accompanied by dissents or concurrences from any of the justices—all of which is
Even with slightly lighter attendance at MjBizCon this year, the quality of conversations and the overall engagement felt stronger than ever. The insights, candor, and determination that filled the hallways and side events were a powerful reminder of why this industry keeps pushing forward despite constant headwinds. The event team delivered a well-run, thoughtful conference
Yesterday afternoon, the Washington Post and other sources reported that President Trump is expected to issue an executive order directing federal agencies to reclassify marijuana, to Schedule III. That’s some sexy reportage, although WaPo’s sources cautioned that “Trump could still change his mind” and “[a] White House official said no final decisions have been made
